UniProt ID | ZN335_HUMAN | |
---|---|---|
UniProt AC | Q9H4Z2 | |
Protein Name | Zinc finger protein 335 | |
Gene Name | ZNF335 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1342 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component or associated component of some histone methyltransferase complexes may regulate transcription through recruitment of those complexes on gene promoters. Enhances ligand-dependent transcriptional activation by nuclear hormone receptors. Plays an important role in neural progenitor cell proliferation and self-renewal through the regulation of specific genes involved brain development, including REST. Also controls the expression of genes involved in somatic development and regulates, for instance, lymphoblast proliferation.. | |
Protein Sequence | MEENEVESSSDAAPGPGRPEEPSESGLGVGTSEAVSADSSDAAAAPGQAEADDSGVGQSSDRGSRSQEEVSESSSSADPLPNSYLPDSSSVSHGPVAGVTGGPPALVHSSALPDPNMLVSDCTASSSDLGSAIDKIIESTIGPDLIQNCITVTSAEDGGAETTRYLILQGPDDGAPMTSPMSSSTLAHSLAAIEALADGPTSTSTCLEAQGGPSSPVQLPPASGAEEPDLQSLEAMMEVVVVQQFKCKMCQYRSSTKATLLRHMRERHFRPVAAAAAAAGKKGRLRKWSTSTKSQEEEGPEEEDDDDIVDAGAIDDLEEDSDYNPAEDEPRGRQLRLQRPTPSTPRPRRRPGRPRKLPRLEISDLPDGVEGEPLVSSQSGQSPPEPQDPEAPSSSGPGHLVAMGKVSRTPVEAGVSQSDAENAAPSCPDEHDTLPRRRGRPSRRFLGKKYRKYYYKSPKPLLRPFLCRICGSRFLSHEDLRFHVNSHEAGDPQLFKCLQCSYRSRRWSSLKEHMFNHVGSKPYKCDECSYTSVYRKDVIRHAAVHSRDRKKRPDPTPKLSSFPCPVCGRVYPMQKRLTQHMKTHSTEKPHMCDKCGKSFKKRYTFKMHLLTHIQAVANRRFKCEFCEFVCEDKKALLNHQLSHVSDKPFKCSFCPYRTFREDFLLSHVAVKHTGAKPFACEYCHFSTRHKKNLRLHVRCRHASSFEEWGRRHPEEPPSRRRPFFSLQQIEELKQQHSAAPGPPPSSPGPPEIPPEATTFQSSEAPSLLCSDTLGGATIIYQQGAEESTAMATQTALDLLLNMSAQRELGGTALQVAVVKSEDVEAGLASPGGQPSPEGATPQVVTLHVAEPGGGAAAESQLGPPDLPQITLAPGPFGGTGYSVITAPPMEEGTSAPGTPYSEEPAGEAAQAVVVSDTLKEAGTHYIMATDGTQLHHIELTADGSISFPSPDALASGAKWPLLQCGGLPRDGPEPPSPAKTHCVGDSQSSASSPPATSKALGLAVPPSPPSAATAASKKFSCKICAEAFPGRAEMESHKRAHAGPGAFKCPDCPFSARQWPEVRAHMAQHSSLRPHQCSQCSFASKNKKDLRRHMLTHTKEKPFACHLCGQRFNRNGHLKFHIQRLHSPDGRKSGTPTARAPTQTPTQTIILNSDDETLATLHTALQSSHGVLGPERLQQALSQEHIIVAQEQTVTNQEEAAYIQEITTADGQTVQHLVTSDNQVQYIISQDGVQHLLPQEYVVVPEGHHIQVQEGQITHIQYEQGAPFLQESQIQYVPVSPGQQLVTQAQLEAAAHSAVTAVADAAMAQAQGLFGTDETVPEHIQQLQHQGIEYDVITLADD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
252 | Phosphorylation | FKCKMCQYRSSTKAT EECCCCCCCCCCHHH | 13.92 | - | |
281 | Acetylation | AAAAAAGKKGRLRKW HHHHHCCCCCCCCCC | 47.53 | 26051181 | |
289 | Phosphorylation | KGRLRKWSTSTKSQE CCCCCCCCCCCCCCC | 18.60 | 27794612 | |
290 | Phosphorylation | GRLRKWSTSTKSQEE CCCCCCCCCCCCCCC | 39.02 | 27794612 | |
291 | Phosphorylation | RLRKWSTSTKSQEEE CCCCCCCCCCCCCCC | 28.46 | 27794612 | |
292 | Phosphorylation | LRKWSTSTKSQEEEG CCCCCCCCCCCCCCC | 34.50 | 27794612 | |
341 | Phosphorylation | QLRLQRPTPSTPRPR CCCCCCCCCCCCCCC | 31.87 | 28555341 | |
343 | Phosphorylation | RLQRPTPSTPRPRRR CCCCCCCCCCCCCCC | 54.22 | 23898821 | |
344 | Phosphorylation | LQRPTPSTPRPRRRP CCCCCCCCCCCCCCC | 25.23 | 23898821 | |
376 | Phosphorylation | VEGEPLVSSQSGQSP CCCCCCCCCCCCCCC | 30.28 | 28348404 | |
377 | Phosphorylation | EGEPLVSSQSGQSPP CCCCCCCCCCCCCCC | 22.38 | 28348404 | |
379 | Phosphorylation | EPLVSSQSGQSPPEP CCCCCCCCCCCCCCC | 40.52 | 28348404 | |
382 | Phosphorylation | VSSQSGQSPPEPQDP CCCCCCCCCCCCCCC | 46.04 | 30576142 | |
407 | Phosphorylation | LVAMGKVSRTPVEAG EEEEEEECCCCCCCC | 33.64 | 26714015 | |
409 | Phosphorylation | AMGKVSRTPVEAGVS EEEEECCCCCCCCCC | 24.95 | 30266825 | |
416 | Phosphorylation | TPVEAGVSQSDAENA CCCCCCCCHHHHHHC | 24.05 | 17525332 | |
418 | Phosphorylation | VEAGVSQSDAENAAP CCCCCCHHHHHHCCC | 31.14 | 30266825 | |
426 | Phosphorylation | DAENAAPSCPDEHDT HHHHCCCCCCCCCCC | 33.29 | 30266825 | |
433 | Phosphorylation | SCPDEHDTLPRRRGR CCCCCCCCCCCCCCC | 40.34 | 26074081 | |
642 | Phosphorylation | ALLNHQLSHVSDKPF HHHHCCCCCCCCCCC | 18.44 | 28555341 | |
645 | Phosphorylation | NHQLSHVSDKPFKCS HCCCCCCCCCCCCCC | 34.20 | 25159151 | |
686 | Phosphorylation | ACEYCHFSTRHKKNL CCEECCCCHHHCCCE | 10.81 | 25627689 | |
687 | Phosphorylation | CEYCHFSTRHKKNLR CEECCCCHHHCCCEE | 35.53 | 25627689 | |
703 | Phosphorylation | HVRCRHASSFEEWGR EEEEECCHHHHHHHH | 29.45 | 28555341 | |
819 | Sumoylation | ALQVAVVKSEDVEAG EEEEEEEEHHHHHHH | 41.34 | - | |
976 | Phosphorylation | RDGPEPPSPAKTHCV CCCCCCCCCCCCCCC | 48.48 | 30266825 | |
980 | Phosphorylation | EPPSPAKTHCVGDSQ CCCCCCCCCCCCCCC | 23.71 | 26552605 | |
986 | Phosphorylation | KTHCVGDSQSSASSP CCCCCCCCCCCCCCC | 26.49 | 23401153 | |
988 | Phosphorylation | HCVGDSQSSASSPPA CCCCCCCCCCCCCCC | 31.65 | 26657352 | |
989 | Phosphorylation | CVGDSQSSASSPPAT CCCCCCCCCCCCCCC | 25.24 | 28450419 | |
991 | Phosphorylation | GDSQSSASSPPATSK CCCCCCCCCCCCCHH | 45.38 | 23401153 | |
992 | Phosphorylation | DSQSSASSPPATSKA CCCCCCCCCCCCHHH | 34.32 | 23401153 | |
996 | Phosphorylation | SASSPPATSKALGLA CCCCCCCCHHHCCCC | 36.21 | 28450419 | |
997 | Phosphorylation | ASSPPATSKALGLAV CCCCCCCHHHCCCCC | 20.31 | 28450419 | |
997 | O-linked_Glycosylation | ASSPPATSKALGLAV CCCCCCCHHHCCCCC | 20.31 | 30059200 | |
1007 | Phosphorylation | LGLAVPPSPPSAATA CCCCCCCCCCCHHHH | 43.29 | 25159151 | |
1010 | Phosphorylation | AVPPSPPSAATAASK CCCCCCCCHHHHHCC | 33.64 | 23312004 | |
1013 | Phosphorylation | PSPPSAATAASKKFS CCCCCHHHHHCCCCC | 23.60 | 27050516 | |
1016 | Phosphorylation | PSAATAASKKFSCKI CCHHHHHCCCCCCCC | 33.64 | 23312004 | |
1022 | Sumoylation | ASKKFSCKICAEAFP HCCCCCCCCCHHHCC | 39.35 | 28112733 | |
1038 | Ubiquitination | RAEMESHKRAHAGPG HHHHHHHCCCCCCCC | 61.63 | - | |
1098 | Phosphorylation | RRHMLTHTKEKPFAC HHHHHHCCCCCCCEE | 35.35 | 29214152 | |
1127 | Phosphorylation | FHIQRLHSPDGRKSG EEEEECCCCCCCCCC | 29.31 | 30576142 | |
1133 | Phosphorylation | HSPDGRKSGTPTARA CCCCCCCCCCCCCCC | 46.68 | 26074081 | |
1135 | Phosphorylation | PDGRKSGTPTARAPT CCCCCCCCCCCCCCC | 25.26 | 26074081 | |
1137 | Phosphorylation | GRKSGTPTARAPTQT CCCCCCCCCCCCCCC | 28.72 | 26074081 | |
1142 | Phosphorylation | TPTARAPTQTPTQTI CCCCCCCCCCCCEEE | 44.05 | 28450419 | |
1144 | Phosphorylation | TARAPTQTPTQTIIL CCCCCCCCCCEEEEE | 30.68 | 28450419 | |
1146 | Phosphorylation | RAPTQTPTQTIILNS CCCCCCCCEEEEECC | 41.55 | 28450419 | |
1148 | Phosphorylation | PTQTPTQTIILNSDD CCCCCCEEEEECCCC | 16.68 | 28464451 | |
1153 | Phosphorylation | TQTIILNSDDETLAT CEEEEECCCCHHHHH | 42.89 | 22115753 | |
1157 | Phosphorylation | ILNSDDETLATLHTA EECCCCHHHHHHHHH | 28.78 | 28450419 | |
1160 | Phosphorylation | SDDETLATLHTALQS CCCHHHHHHHHHHHH | 23.37 | 28464451 | |
1163 | Phosphorylation | ETLATLHTALQSSHG HHHHHHHHHHHHCCC | 31.98 | 28450419 | |
1167 | Phosphorylation | TLHTALQSSHGVLGP HHHHHHHHCCCCCCH | 25.75 | 25002506 | |
1168 | Phosphorylation | LHTALQSSHGVLGPE HHHHHHHCCCCCCHH | 15.99 | 25002506 | |
1280 | Phosphorylation | QIQYVPVSPGQQLVT CCEEEECCCCHHHEH | 19.76 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN335_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN335_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN335_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HCFC1_HUMAN | HCFC1 | physical | 19131338 | |
CCAR2_HUMAN | CCAR2 | physical | 19131338 | |
EMSY_HUMAN | C11orf30 | physical | 19131338 | |
RBBP5_HUMAN | RBBP5 | physical | 19131338 | |
ASH2L_HUMAN | ASH2L | physical | 19131338 | |
WDR5_HUMAN | WDR5 | physical | 19131338 | |
CNOT9_RAT | Rqcd1 | physical | 18180299 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615095 | Microcephaly 10, primary, autosomal recessive (MCPH10) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-976, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1153, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-976, AND MASSSPECTROMETRY. |